OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 10, pp. 1089-1108
Open Access | Times Cited: 18

Showing 18 citing articles:

Advances in Cell and Immune Therapies for Melanoma
Tanase Timis, Sanda Buruiana, Delia Dima, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 98-98
Open Access

Recent Advances in Anticancer Strategies
Zhiwei Hu, Hassan Bousbaa
Cancers (2025) Vol. 17, Iss. 2, pp. 173-173
Open Access

Injecting hope: the potential of intratumoral immunotherapy for locally advanced and metastatic cancer
Markéta Skaličková, Katerina Hadrava Vanova, Ondřej Uher, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access

Translational study of the regulatory mechanism by which immune synapses enhance immune cell function
Yahui Li, Xiao‐Jun Huang, Xiang‐Yu Zhao
Cancer Letters (2025) Vol. 614, pp. 217542-217542
Closed Access

NK cells in renal cell carcinoma and its implications for CAR-NK therapy
Xinwei Li, Yuanpeng Zhang, Yuzhong Ye, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access

The Emerging Role of CD8+ T Cells in Shaping Treatment Outcomes of Patients with MDS and AML
Athanasios Tasis, Theodoros Spyropoulos, Ioannis Mitroulis
Cancers (2025) Vol. 17, Iss. 5, pp. 749-749
Open Access

A 5-Year Update on the Clinical Development of Cancer Cell-Based Vaccines for Glioblastoma Multiforme
Almohanad A. Alkayyal, Ahmad Bakur Mahmoud
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 376-376
Open Access

Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks
Caroline Diorio, David T. Teachey, Stephan A. Grupp
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 3

Rationale, in silico docking, ADMET profile, design, synthesis and cytotoxicity evaluations of phthalazine derivatives as VEGFR-2 inhibitors and apoptosis inducers
Hatem Hussein Bayoumi, Mohamed‐Kamal Ibrahim, Mohammed A. Dahab, et al.
RSC Advances (2024) Vol. 14, Iss. 37, pp. 27110-27121
Open Access | Times Cited: 2

Evaluation of efficacy, safety and underlying mechanism on Traditional Chinese medicine as synergistic agents for cancer immunotherapy: A preclinical systematic review and meta-analysis
Jing Li, Shipeng Fan, Hongxia Li, et al.
Journal of Ethnopharmacology (2024) Vol. 338, pp. 119035-119035
Closed Access | Times Cited: 2

Identification and Analysis of Microplastic Aggregation in CAR-T Cells
Yin Zhao, Yizhen Huang, Yangmin Zhu, et al.
Journal of Hazardous Materials (2024) Vol. 480, pp. 136351-136351
Closed Access | Times Cited: 1

Getting the right combination to break the epigenetic code
Seda S. Tolu, Aaron D. Viny, Jennifer E. Amengual, et al.
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 1

Emerging Technologies for the Assessment of Natural Killer Cell Activity
Anna Luise Grab, Alexander Nesterov‐Mueller
J — Multidisciplinary Scientific Journal (2024) Vol. 7, Iss. 4, pp. 457-471
Open Access

Granzyme mRNA-miRNA interaction and its implication to functional impact
Hyeon-Young Kim, Jung Min Kim, Young Kee Shin
Genes & Genomics (2024) Vol. 46, Iss. 12, pp. 1495-1506
Closed Access

Layered Double Hydroxides for Radium‐223 Targeted Alpha Therapy with Elicitation of the Immune Response
Mengdie Yang, Jianguo Li, Z. Y. Han, et al.
Advanced Healthcare Materials (2024)
Closed Access

An integral membrane constitutively active heparanase enhances the tumor infiltration capability of NK cells
Sofia Libório‐Ramos, Isaac Quiros‐Fernandez, Neta Ilan, et al.
OncoImmunology (2024) Vol. 14, Iss. 1
Open Access

Page 1

Scroll to top